Company Filing History:
Years Active: 2017
Title: Lluis Solà Carandell: Innovator in Pharmaceutical Crystallization
Introduction
Lluis Solà Carandell is a notable inventor based in Tarragona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the area of crystalline forms of compounds. His work has implications for drug formulation and delivery, enhancing the efficacy of medications.
Latest Patents
Lluis holds a patent for a monoclinic crystalline form of asenapine maleate with a specific particle size distribution. This innovative form is characterized by not being micronized and has a particle size distribution defined by a d90 of 40 µm or less. The patent also describes a process for preparing this crystalline form, which involves mixing monoclinic asenapine maleate with an organic solvent that acts as an antisolvent, stirring the mixture at a temperature between 15 and 60°C, and collecting the resulting crystals.
Career Highlights
Lluis Solà Carandell is associated with Laboratorios Lesvi, S.L., where he applies his expertise in pharmaceutical development. His work focuses on improving the properties of pharmaceutical compounds, which is crucial for enhancing drug performance and patient outcomes.
Collaborations
He has collaborated with notable colleagues such as Jordi Cerón Bertran and Glòria Freixas Pascual, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Lluis Solà Carandell's contributions to the field of pharmaceuticals through his innovative patent on asenapine maleate exemplify the importance of research and development in improving drug formulations. His work continues to impact the pharmaceutical industry positively.